000 | 01946 a2200529 4500 | ||
---|---|---|---|
005 | 20250515075244.0 | ||
264 | 0 | _c20071024 | |
008 | 200710s 0 0 eng d | ||
022 | _a0268-3369 | ||
024 | 7 |
_a10.1038/sj.bmt.1705778 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBurroughs, L M | |
245 | 0 | 0 |
_aIntensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders. _h[electronic resource] |
260 |
_bBone marrow transplantation _cOct 2007 |
||
300 |
_a633-42 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aCause of Death |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGraft vs Host Disease _xepidemiology |
650 | 0 | 4 |
_aHLA Antigens _ximmunology |
650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
650 | 0 | 4 | _aHistocompatibility Testing |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunologic Deficiency Syndromes _xtherapy |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aSurvivors |
650 | 0 | 4 | _aTransplantation Chimera |
650 | 0 | 4 | _aTransplantation Conditioning |
650 | 0 | 4 | _aWhole-Body Irradiation |
700 | 1 | _aStorb, R | |
700 | 1 | _aLeisenring, W M | |
700 | 1 | _aPulsipher, M A | |
700 | 1 | _aLoken, M R | |
700 | 1 | _aTorgerson, T R | |
700 | 1 | _aOchs, H D | |
700 | 1 | _aWoolfrey, A E | |
773 | 0 |
_tBone marrow transplantation _gvol. 40 _gno. 7 _gp. 633-42 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bmt.1705778 _zAvailable from publisher's website |
999 |
_c17194225 _d17194225 |